Viridian Capital's latest report shows cannabis stocks pricing in no rescheduling or 280E relief, leaving MSOs stuck in ...

On Feb. 5, Aurora Cannabis reported its fiscal third-quarter results for the period ended Dec. 31. The cannabis company ...

Julian Lin updates his views on cannabis REITs IIPR and NewLake Capital and shares his changed thesis on MSOs.

Robert F. Kennedy Jr., seen as pro-cannabis, is heading toward expected approval as Health and Human Services secretary, ...

CNBS's portfolio is less concentrated in a few stocks compared to MSOS, reducing risk. Check out why I rate the fund a buy.

Aurora Cannabis posted Q3 FY25 net revenue of CA$88.2 million, driven by medical cannabis and plant propagation growth, with ...

Canopy’s stock reversed on earnings after seeing a rally sparked by the possibility of marijuana reform in the U.S.

While still prohibited by federal law, most states and D.C. have legalized cannabis for medical or recreational use (or both) ...

The Global Cannabis Stock Index, which is dollar-denominated and based upon the prices of the U.S. listing for each member, is rebalanced quarterly, with each member weighted equally at that time.